Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Clinical trial NCT01324960 · WITHDRAWN
Trial details
- NCT number
- NCT01324960
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.